Hypertensive nephropathy classification

Hypertensive nephropathy Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Differentiating Hypertensive Nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Abdominal X Ray
CT
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hypertensive nephropathy classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hypertensive nephropathy classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hypertensive nephropathy classification
CDC on Hypertensive nephropathy classification
Hypertensive nephropathy classification in the news
Blogs on Hypertensive nephropathy classification
Directions to Hospitals Treating Hypertensive nephropathy
Risk calculators and risk factors for Hypertensive nephropathy classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Classification

Hypertensive nephropathy is divided into two distinct entities:

• Benign arteriolar nephrosclerosis
  • Seen in patients who are hypertensive for a long period of time (> 150/90 mm Hg) but has not progressed to malignant stage.
• Malignant (accelerated) arteriolar nephrosclerosis
  • Characterized by sudden elevation of blood pressure (diastolic pressure > 130 mm Hg) along with papilledema, central nervous system manifestations like confusion, cardiac decompensation and acute progressive decline in renal function.